18F-FDG PET brain in Parkinsonism
Objective: To determine if 18F-FDG PET can differentiate Parkinson's Disease from Parkinson's-Plus syndromes Background: Parkinsonism is a clinical syndrome of tremor, rigidity, bradykinesia and postural…Maintenance of safinamide 100 mg daily long-term
Objective: Evaluating the maintenance of safinamide 100 mg daily as a long-term treatment. Background: The effects of safinamide were investigated in studies 016, 018 and…Effectiveness of an Activity-based Integrative Group Therapy (ParkEASE) on Health-Related-Quality of Life of People with Parkinson’s Disease and of their Caregivers: A Retrospective Pilot Study
Objective: To evaluate the effectiveness of ParkEASE in improving health related quality of life(HRQoL) of people with Parkinson’s Disease(PD) and their caregivers. This pilot study…Impact of a Parkinson’s Disease-Specific Order Set on Inpatient Medication Administration
Objective: To determine the efficacy of a Parkinson’s Disease (PD)-Specific Electronic Medical Record (EMR) Order Set in reducing the rate of medication mis-administration for PD…Personal KinetiGraph™ Movement Recording System: An Assessment of Utility in a Movement Disorder Clinic
Objective: The objective of this open-label study was to evaluate the clinical utility of the Personal KinetiGraph™ (PKG) Movement Recording System in the care of…Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease
Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study
Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…Integrated whole exome sequencing and chromosomal microarray in familial Parkinson’s disease
Objective: To determine whether whole exome sequencing (WES) plus chromosomal microarray analysis (CMA) yield a genetic etiology in a cohort of 110 individuals with familial…Relationship between cyclooxygenase-2 gene polymorphisms and Parkinson’s disease susceptibility in Chinese Han population
Objective: To investigate relationship between the cyclooxygenase-2 (COX-2) gene promoter region (rs20417, rs689466, rs689465) and 3'untranslated region (rs5275) polymorphisms with Parkinson’s disease (PD) susceptibility in…Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance of Anti Parkinson’s Therapy
Objective: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than 7 million people worldwide. However, treatment outcome in many patients…
- « Previous Page
- 1
- …
- 288
- 289
- 290
- 291
- 292
- …
- 425
- Next Page »